Generate Biomedicines Picks First Targets To Test Its AI-Based Drug Discovery Revolution

Mutation-Resistant COVID-19 Therapy Is First Candidate

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.